EUVIMEDEUVIMED entdecken
Crossref

Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4

Maohua Cai, Furong Ma, Can Hu, Haobin Li, Fei Cao, Yulong Li, Jinyun Dong, Jiang-Jiang Qin

Bioorganic & Medicinal Chemistry · 2023-07 · 90 · 117352

DOI: 10.1016/j.bmc.2023.117352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2023-07. Verfasst von Maohua Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Hauptthemen laut MEDLINE: Iron, Lipid Peroxides. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a new type of regulated, non-apoptotic cell death driven by iron-dependent phospholipid peroxidation. Inducing cell ferroptosis by inactivating glutathione peroxidase 4 (GPX4) has been considered as an effective cancer treatment strategy, but only few GPX4 inhibitors have been reported to date. Targeted protein degradation is receiving increasing attention in the discovery and development of therapeutic modality, particularly proteolysis targeting chimeras (PROTACs). Herein, we reported the design, synthesis, and evaluation of different types of GPX4-targeting PROTACs using ML162 derivatives and ligands for CRBN/VHL E3 ligases. Among them, CRBN-based PROTAC GDC-11 showed a relatively balanced biological profile in GPX4 degradation (degradation rate of 33% at 10 μM), cytotoxicity (IC50 = 11.69 μM), and lipid peroxides accumulation (2-foldincreaserelatedtoDMSO), suggesting a typical characteristic of ferroptosis. In silico docking and quantum chemistry theoretical calculations provided a plausible explanation for the moderate degrading effect of these synthesized PROTACs. Overall, this work lays the foundation for subsequent studies of GPX4-targeting PROTACs, and further design and synthesis of GPX4-targeting degrader are currently in progress in our group, which will be reported in due course.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IronLipid PeroxidesProteolysisPhospholipid Hydroperoxide Glutathione PeroxidasePeroxidesProteolysis Targeting Chimera

Stichwörter der Autor:innen

FerroptosisGPX4ML162PROTAC

Substanzen

Phospholipid Hydroperoxide Glutathione PeroxidaseIronLipid PeroxidesPeroxidesProteolysis Targeting Chimera

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China; Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer of Zh…
  • College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310032, China.

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Cai, M., Ma, F., Hu, C., Li, H., Cao, F., Li, Y., Dong, J., & Qin, J. J. (2023). Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4. Bioorganic & Medicinal Chemistry, 90, 117352. https://doi.org/10.1016/j.bmc.2023.117352

Vancouver

Cai M, Ma F, Hu C, Li H, Cao F, Li Y, et al. Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4. Bioorganic & Medicinal Chemistry. 2023;90:117352. doi:10.1016/j.bmc.2023.117352

BibTeX
@article{Cai2023,
  author = {Cai, Maohua and Ma, Furong and Hu, Can and Li, Haobin and Cao, Fei and Li, Yulong and Dong, Jinyun and Qin, Jiang-Jiang},
  title = {Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4},
  journal = {Bioorganic & Medicinal Chemistry},
  year = {2023},
  volume = {90},
  pages = {117352},
  doi = {10.1016/j.bmc.2023.117352}
}
Kostenlos starten →